Montreal, Canada

Mahnaz Akhavan


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Montreal, CA (2009 - 2012)
  • Toronto, CA (2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mahnaz Akhavan: Innovator in Stem Cell Research

Introduction

Mahnaz Akhavan is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of stem cell research, holding a total of 3 patents. Her work focuses on the development and application of multipotent stem cells, which have the potential to revolutionize regenerative medicine.

Latest Patents

One of her latest patents is titled "Multipotent stem cells from peripheral tissues and uses thereof." This invention relates to multipotent stem cells that are purified from the peripheral tissue of mammals. These cells are capable of differentiating into both neural and non-neural cell types. The significance of this invention lies in its provision of an accessible source for autologous transplantation into the central nervous system (CNS), peripheral nervous system (PNS), and other damaged tissues.

Career Highlights

Mahnaz Akhavan is affiliated with McGill University, where she conducts her research and contributes to the academic community. Her innovative work has garnered attention and respect within the scientific community, highlighting her role as a leading figure in stem cell research.

Collaborations

Mahnaz collaborates with esteemed colleagues such as Jean George Toma and Karl J L Fernandes, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Mahnaz Akhavan's contributions to stem cell research exemplify her dedication to advancing medical science. Her innovative patents and collaborations position her as a key player in the field, paving the way for future breakthroughs in regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…